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Leukotrienes are a unique class of potent humoral and cellular mediators that are 
generated by the specific lipoxygenation and  subsequent  enzymatic conversions of 
arachidonic  acid  in  basophils,  mastocytoma  cells,  polymorphonuclear  leukocytes 
(PMN)  and mononuclear leukocytes, and human  lung tissue  (1-6). The structural 
characteristics shared by the leukotriene mediators include three conjugated double 
bonds, a 5-hydroxy group, and either a 6-sulfido-cysteine(yl) or 12-hydroxy group. 5- 
hydroxy-6-sulfido-glutathionyl-eicosa-7,9,11,14-tetraenoic acid  (leukotriene  (34  [or 
LT(34], where the subscript  4  indicates  the  total number of double bonds)  and  5- 
hydroxy-6-sulfido-cysteinyl-glycine-7,9,11,14-tetraenoic acid  (LTD4), which  are  the 
principal active constituents of the slow-reacting substance of anaphylaxis  (termed 
SRS-A), constrict pulmonary airways with a potency up to 20,000 times greater than 
that of histamine and alter the tone and permeability of the microvasculature (7). 
5(S),12(R)-di-hydroxy-eicosa-6,8,10(trans/trans/cis),14(cis)-tetraenoic acid,  which  is 
designated LTB4 (6), is chemotactic and chemokinetic for human and rat PMN and, 
to a  lesser extent, mononuclear leukocytes (8-10). The maximal human neutrophil 
chemotactic response elicited by LTB4 is similar in  magnitude to those evoked by 
synthetic formyl-methionyl peptides or fragments of the fifth component of human 
complement, and the neutrophil chemotactic potency of LTB4 is far greater than that 
of the mono-hydroxy-eicosatetraenoic acids (HETE) derived from arachidonic acid, 
whereas neither LT(34 nor platelet-derived tri-HETE exhibit leukocyte chemotactic 
activity (8). The results of our study indicate that the conformation of the hydroxyl- 
groups and the geometry of the double bonds in the conjugated triene are the critical 
structural determinants of the potency of LTB4 as a neutrophil chemotactic factor. 
Materials and Methods 
Preparation and Purification of Lipoxygenase Products of Arachidonic Acid.  Neutrophils that had 
been isolated from venous blood of normal subjects were incubated for 30 rain at 37°(2 at a 
concentration of 5 ×  10  7 neutrophils/ml in Hanks' balanced salt solution containing 0.02 M 
Tris-HCll (pH 8), 10/LM indomethacin, 5/zM calcium ionophore A23187, and 0.5 mg/ml of 
arachidonic acid. The HETE were extracted and resolved from both the residual arachidonic 
acid and more polar products by silicic acid column chromatography (6, 8). LTB4 and 5-HETE 
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were purified by reverse-phase high performance liquid chromatography (HPLC)  on a  C18 
ODS column (Ultrasphere; Ahex Scientific, Inc., Berkeley, Calif.) that was developed isocrati- 
tally at a  flow rate of 1 ml/min with methanol:water:glacial acetic acid (78:22:0.01, vol:vol: 
vol). The 5,12-di-HETE and 5,6-di-HETE isomers contained in the eluates of the silicic acid 
column  were resolved from  LTB4  and  mcno-HETE  and were partially purified by reverse- 
phase HPLC on Nucleosil C-18, 5/Lm (Machery-Nagel, Dfiren, Federal Republic of Germany) 
for 60  min.  The  5,12-di-HETE  and  the  5,6-di-HETE  were  purified by  rechromatography 
separately on  the Nueleosil column utilizing methanol:water:glacial acetic acid (65:35:0.01, 
vol:vol:voi) and methanol:water:glacial ac,etic acid (75:25:0.01, vol:vol:vol), respectively. The 
highly purified LTB4 and di-HETE isomers contained <1% total of the other isomers. 
The chromatographic characteristics of the two 5,6-di-HETE stereoisomers, for which the 
conformation of the hydroxyl-groups and the geometry of the double bonds have not been 
determined, and  the two 5,12-di-HETE with 6,8,10(all-trans),  14(cis)-double bonds, termed 
5,12-alt-trans-di-HETE, have been described previously (6). 5,6-di-HETE-a eluted before 5,6- 
di-Hete-b from  the second Nucleosil C-18 column.  The 5,12-di-HETE were converted into 
dimenthoxycarbonyl derivatives, subjected to oxidative ozonolysis, and  treated with diazo- 
methane,  and  the  products  were  analyzed  by  gas  chromatography-mass  spectrometry  to 
determine the configuration of the 5- and  12-hydroxy-groups (6). The triene portion of LTB4 
consists of one cis- and two trans- double bonds, but the position of the cis- bond has not been 
established unequivocally. LTB4 was methylated by reaction with a  500-fold molar excess of 
diazomethane in ethyl ether for 10 min at room temperature and was acetylated in pyridine by 
reaction with a  100-fold molar excess of acetic anhydride for 20 rain at room temperature; both 
procedures were carried out  in an  argon environment  (11,  12). The  identity of each of the 
purified products was confirmed by ultraviolet light absorption spectroscopy, infrared spectros- 
copy, and  gas chromatography-mass spectrometry; the products were quantified by optical 
density at characteristic wavelengths of maximal absorption (6). 
Assessment of human neutrophil migration.  Chemotaxis of human neutrophils of >96%  purity 
was assayed by a modification of the Boyden technique using chambers with a 0.2 ml blind- 
end stimulus compartment  (Neuro Probe, Inc., Bethesda, Md.)  and  filters with  3-/~m pores 
(Sartorius, Science Essentials Division of Beckman Instruments, Inc., Wakefield, Mass.) (8,  11, 
12). Chemotactic fragments of the fifth component of human complement (C5) were prepared 
as described (11). The chemotactic responses were expressed as net neutrophils/high-power field 
(hpf) after subtraction of the background level of migration in the absence of a stimulus. In 
studies designed to examine the inhibition of the neutrophil chemotaetic response to LTB4 by 
derivatives of LTB4,  the  native  principle and  the  derivative were  present  together  in  the 
chemotactic factor compartment and the response to the derivative alone was subtracted from 
the activity of the mixture. A standard two-sample Student's t-test was used to calculate levels 
of significance. 
Results 
LTB4 elicited a  neutrophil chemotactic response that was detectable at a  concen- 
tration of 0.3 ng/ml or ~ 10  -9 M  and was maximal at 30 ng/ml or ~ 10  -7 M  (Fig.  1). 
The maximal neutrophil chemotactic response to LTB~ was similar in magnitude to 
those evoked by the chemotactic fragments of C5  (56.6 -I- 7.4, mean -  SD, n =  4) or 
by 10 -8 M  formyl-methionyl-leucyl-phenylalanine (f-Met-Leu-Phe) (60.3 ±  9.2). The 
other  di-HETE  examined  were  significantly less potent  than  LTB~  as chemotactic 
stimuli, but at a concentration of 1,000 ng/ml evoked maximal chemotactic responses 
that  were  not  significantly different  from  that  seen  with  LTB4  at  10  ng/ml.  Thus 
LTB4  was  ~100-fold  more  potent  than  the  other  di-HETE,  when  comparing  the 
concentrations required to stimulate maximal chemotactic responses. An analysis of 
the concentrations needed to achieve a  response equal  to 50%  of the maximal level 
indicated  that  the  ratio  of potency  of LTB4  to  the  analogues  ranged  from  15  for 
stereoisomer  a  of the  5,6-di-HETE  to  >100  for  5(S),12(S)-all-trans-di-HETE. The 484  GOETZL  AND  PICKETT  BRIEF  DEFINITIVE  REPORT 
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FIo.  1.  Human neutrophil chemotactic activity of derivatives  and analogues  of leukotriene  B4. 
The points and brackets represent the mean 4- SD of the results of eight determinations of activity 
for LTB4, five for acetyl-LTB4 and four for the other factors. The designation "all-trans" refers to 
the geometry of only the conjugated double bonds in the triene portion of the molecule. LTB4 was 
significantly  more chemotactic for neutrophils (P <  0.01) than was acetyl-LTB4 at concentrations 
of 0.3-10 ng/ml, 5,6-di-HETE-a at 0.3-30 ng/ml, and the other analogues at 0.3-100  ng/ml. 
5(S),12(R)-all-trans-di-HETE,  in  which  the  5-  and  12-hydroxyl groups  possess  a 
different conformation, was substantially more potent than the isomer with optically 
equivalent 5(S)- and 12(S)-hydroxyl substituents. 
Acetylation of LTB4 decreased the chemotactic activity significantly at concentra- 
tions of 0.3-10 ng/ml, but not at maximally active concentrations, while incubation 
in pyridine alone or methyl esterification had no effect (Fig. 1). In contrast, the results 
of parallel experiments showed that the methyl ester of 5-HETE had significantly less 
neutrophil chemotactic activity than 5-HETE at concentrations of 200-5,000 ng/ml, 
whereas acetyl-5-HETE expressed neutrophil chemotactic activity that ranged from 
75-87%,  78-91%, and 82-94% that of 5-HETE at concentrations of 200,  1,000 and 
5,000 ng/ml, respectively. The presence of minimally chemotactic concentrations of 
acetyl-LTB4 suppressed the chemotactic responses to LTB4 in proportion to the molar 
ratio  of the  factors  (Fig.  2),  but  had  no  effect on  the  responses  to  chemotactic 
fragments of C5 or to f-Met-Leu-Phe. At an equimolar concentration, acetyl-LTB4 
inhibited  by  ~50%  the  chemotactic responses  to  1 ng/ml  and  4  ng/ml  of LTB4. 
Incubation of portions of neutrophils with 4  ng/ml  and  10 ng/ml of acetyl-LTB4, 
followed by washing, failed to suppress the subsequent chemotactic response to 1 ng/ 
ml of LTB4 relative to neutrophils preincubated in buffer alone. LTB4-methyl ester 
had only a  minimal inhibitory effect that reached 20% at a  10-fold ratio of LTB4- 
methyl ester:LTB4. 
Discussion 
LTB4 elicits a maximal neutrophil chemotactic response and a response that is one- 
half of the maximal level at concentrations of~ 10  -7 M and ~6 X 10  -9 M, respectively 
(Fig. 1), which are similar in magnitude to those evoked by 4 X  10  -6 M  and 4 ×  10  -~ 
M  5-HETE (13), and by 1.7 ×  10  -s M  and  1.3 X  10  -9 M  CSa (14). The neutrophil 
chemotactic activity of acetyl-LTB4 is significantly less than that of LTB4 at concen- GOETZL  AND  PICKETT  BRIEF  DEFINITIVE  REPORT  485 
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Fro.  2.  Inhibition of the human  neutropbil chemotactic response to leukotriene B4 by acetyl- 
leukotriene ]34. The points and brackets represent the mean :1: SD of the results of four assays with 
neutrophils from different subjects. The control chemotactic responses (100%) to 1 ng/ml and 4 ng/ 
ml of LTB4 ranged from 18.4-26.7 and from 33.6-41.9 net neutrophils/hpf, respectively. *, P < 
0.01; and +, P< 0.05. 
trations on the ascending portion of the dose-response curve, whereas the chemotactic 
potency of acetyl-5-HETE and of 5-HETE are similar. Free hydroxyl-group(s) thus 
are critical determinants of the chemotactic potency of LTB4, but are not required for 
the expression of maximal chemotactic activity at higher concentrations. In contrast, 
methylation of the carboxyl group substantially suppressed the chemotactic potency 
and maximal activity of 5-HETE, but  had no significant effect on the  function  of 
LTB4. 
The availability of a series of other highly purified di-HETE, that were generated 
by neutrophils, permitted an analysis of the functional role of the double bonds in the 
conjugated triene of LTB4. The triene of LTB4, as for that of LTC4 and LTD4, consists 
of one cis- and two trans- double bonds, but the positions of the bonds have not been 
established  unequivocally  for  LTB4  (3,  5,  6).  The  5(S),12(R)-all-trans-di-HETE 
isomer, which differs from LTB4 only in having a trans-double bond in place of a cis- 
double bond in the triene portion of the molecule (6), is significantly less potent than 
LTB4, but evokes a maximal chemotactic response of similar magnitude (Fig.  1). The 
cis-double bond and the free hydroxyl-group(s) thus appear to be critical determinants 
of the potency of LTB4, but are not required  to attain maximal activity unlike the 
free carboxyl-group of 5-HETE. Although the other 5,12-di-HETE and both 5,6-di- 
HETE isomers also were less potent than  LTB4, differences in the conformation or 
position of the second hydroxyl-group as well as in the structure of the triene may 
have contributed to the altered function. 
The capacity of minimally chemotactic concentrations  of acetyl-LTB4 to inhibit 
selectively the human neutrophil chemotactic response to LTB4 is reminiscent of the 
competitive inhibition of the chemotactic responses to 5-HETE by 5-HETE methyl 
ester (9) and to f-Met-Leu-Phe by several chemotactically inactive peptide analogues 
(15,  16).  That  the washing of neutrophils  that  had been preincubated with acetyl- 
LTB4 fully reversed the suppression of the chemotactic response to LTB4 suggests a 
competitive  mechanism  of inhibition.  The  results  of competitive  binding  studies 
indicate  that  some  inactive  peptide  analogues  inhibit  the  chemotactic  and  other 486  GOETZL AND PICKETT  BRIEF  DEFINITIVE REPORT 
activities of f-Met-Leu-Phe by displacing the stimulus from the receptor, but compa- 
rable binding data are not yet available for LTB4 or the mono-HETE. 
Summary 
A  specific  5(S),12(R)-dihydroxy-eicosa-6,8,10(trans/trans/cis),  14(cis)-tetraenoic 
acid,  designated  leukotriene  B,  is  generated  by the  lipoxygenation and  subsequent 
enzymatic hydration of arachidonic acid  in  a  variety of leukocytes.  Leukotriene B 
elicits a maximal human neutrophil chemotactic response in vitro which is similar in 
magnitude to those evoked by the chemotactic fragment of the fifth component of 
complement,  C5a,  synthetic formyl-methionyl peptides,  and  5-hydroxy-eicosatetra- 
enoic acid (5-HETE). The neutrophil chemotactic potency of purified leukotriene B, 
assessed  by the 50%  effective concentration of 6  ×  10  -9 M~ is equivalent  to that of 
C5a, but is up to 100-fold greater than that of 5-HETE and of other natural di-HETE 
isomers.  5 (S), 12 (R)-di-hydroxy-eicosa-6,8,10  (all-trans), 14 (cis)-tetraenoic  acid,  which 
differs from leukotriene B only in having a trans-double bond in place of a cis-double 
bond in the triene portion of the molecule, and acetyl-leukotriene B are significantly 
less potent neutrophil chemotactic factors than  leukotriene  B,  which indicates  that 
both  the conjugated double bonds and  the  free  hydroxyl-group(s) are  functionally 
critical  determinants.  The capacity of acetyl-leukotriene B  to inhibit  competitively 
and selectively the human neutrophil chemotactic response to equimolar concentra- 
tions of leukotriene B suggests the existence of a  specific subset of receptors for this 
potent lipid mediator. 
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